Detalles de la búsqueda
1.
Revitalization of pioglitazone: the optimum agent to be combined with a sodium-glucose co-transporter-2 inhibitor.
Diabetes Obes Metab
; 18(5): 454-62, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26919068
2.
Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit.
Diabet Med
; 32(3): 305-13, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25472014
3.
The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study.
Diabet Med
; 31(4): 403-11, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24246138
4.
The potential risks of pancreatitis and pancreatic cancer with GLP-1-based therapies are far outweighed by the proven and potential (cardiovascular) benefits.
Diabet Med
; 30(10): 1148-55, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24073725
5.
Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit*.
Diabetes Obes Metab
; 13(8): 703-10, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21410858
6.
Neither evidence from the PROactive study nor the KPNC supports pioglitazone as a tumour promoter.
Diabet Med
; 32(4): 438-9, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773281
7.
Pioglitazone: reports of its death are greatly exaggerated - it is alive and ready to resume saving lives.
Diabet Med
; 32(4): e9-e15, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773282
8.
The Association of British Clinical Diabetologists nationwide exenatide and liraglutide audits suggest a low incidence of acute pancreatitis. Response to Robson. Incretins and pancreatitis--what happens next? A personal viewpoint.
Diabet Med
; 30(12): 1510-1, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24117729
9.
Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon-like peptide 1 (GLP-1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits.
Diabet Med
; 29(5): 690-2, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21988449
10.
The influence of age and metformin treatment status on reported gastrointestinal side effects with liraglutide treatment in type 2 diabetes.
Diabetes Res Clin Pract
; 109(1): 124-9, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25937541
11.
Nontraumatic rhabdomyolysis: an unusual complication of diabetic hyperosmolar nonketotic (HONK) state.
J R Soc Med
; 99(4): 200, 2006 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16574974
12.
Response at 3 months to insulin dose decisions made at exenatide initiation in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide audit.
Diabetes Res Clin Pract
; 93(2): e87-e91, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21636161
13.
Is digital image compression acceptable within diabetic retinopathy screening?
Diabet Med
; 20(9): 766-71, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12925059
Resultados
1 -
13
de 13
1
Próxima >
>>